(Q37822876)

23 August 2017

1 reference

title

Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. (English)

1 reference

23 August 2017

Daisy P F Tsang

1

1 reference

23 August 2017

Alfred S L Cheng

series ordinal

2

1 reference

23 August 2017

publication date

1 January 2011

1 reference

Journal of Gastroenterology and Hepatology

23 August 2017

published in

1 reference

23 August 2017

volume

26

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

19-27

1 reference

Roles of the EZH2 histone methyltransferase in cancer epigenetics

23 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06447.X

Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06447.X

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06447.X

Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M109.002105

10.1111/J.1440-1746.2010.06447.X

12 January 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference